Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to-patient contact

被引:26
作者
Hansen, C. R. [1 ]
Pressler, T. [1 ]
Ridderberg, W. [3 ]
Johansen, H. K. [2 ]
Skov, M. [1 ]
机构
[1] Univ Copenhagen Hosp, Copenhagen CF Ctr, Dept Pediat, Rigshosp, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen Hosp, Copenhagen CF Ctr, Dept Clin Microbiol, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark
关键词
Cross-infection; Achromobacter xylosoxidans; Pulmonary infection; PSEUDOMONAS-AERUGINOSA INFECTION; ALCALIGENES-XYLOSOXIDANS; BURKHOLDERIA-CEPACIA; CHANGING EPIDEMIOLOGY; COLONIZATION; CHILDREN; PATHOGENS; TRANSMISSION; STRAINS; SPREAD;
D O I
10.1016/j.jcf.2013.05.004
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and methods: Achromobacter species leads to chronic infection in an increasing number of CF patients. We report 2 cases of Achromobacter ruhlandii cross-infection between patients after well-described indirect contact. Results: Both cases were young, stable, CF patients without chronic infections and with normal FEV1, but experienced clinical deterioration after visits to the home of a CF patient with A. ruhlandii infection and after sharing facilities with an A. ruhlandii infected CF patient on a skiing vacation, respectively. Both cases became positive for A. ruhlandii in airway secretions and were colonized with A. ruhlandii in their sinuses. Aggressive, long-term antibiotic treatment led to clinical stability. One of the cases developed chronic A. ruhlandii infection. Conclusion: A. species can cause cross-infection even after a short period of indirect contact between infected and non-infected CF patients. Patients should be followed closely for several months before the possibility of cross-infection is ruled out. (C) 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 45 条
[1]  
Aanaes K, 2012, J CYST FIBROS S1, V11, pS53
[2]   Burkholderia cepacia -: a transmissible cystic fibrosis pathogen [J].
Burns, JL .
JOURNAL OF PEDIATRICS, 2001, 139 (05) :618-619
[3]   Achromobacter xylosoxidans in cystic fibrosis:: Prevalence and clinical relevance [J].
De Baets, Frans ;
Schelstraete, Petra ;
Van Daele, Sabine ;
Haerynck, Filomeen ;
Vaneechoutte, Mario .
JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (01) :75-78
[4]   Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center [J].
Denton, M ;
Kerr, K ;
Mooney, L ;
Keer, V ;
Rajgopal, A ;
Brownlee, K ;
Arundel, P ;
Conway, S .
PEDIATRIC PULMONOLOGY, 2002, 34 (04) :257-261
[5]  
Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008
[6]   EPIDEMIOLOGIC INVESTIGATION OF INFECTIONS DUE TO ALCALIGENES SPECIES IN CHILDREN AND PATIENTS WITH CYSTIC-FIBROSIS - USE OF REPETITIVE-ELEMENT-SEQUENCE POLYMERASE CHAIN-REACTION [J].
DUNNE, WM ;
MAISCH, S .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :836-841
[7]   The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre [J].
France, Megan W. ;
Dodd, Mary E. ;
Govan, John R. ;
Doherty, Catherine J. ;
Webb, A. K. ;
Jones, Andrew M. .
JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (05) :368-372
[8]  
Frederiksen B, 1999, PEDIATR PULM, V28, P159, DOI 10.1002/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.3.CO
[9]  
2-T
[10]   Spirometric reference values from a sample of the general US population [J].
Hankinson, JL ;
Odencrantz, JR ;
Fedan, KB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :179-187